369 related articles for article (PubMed ID: 35008414)
1. Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion.
Siddiqui S; Glauben R
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008414
[TBL] [Abstract][Full Text] [Related]
2. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
3. The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity.
Hasan MN; Capuk O; Patel SM; Sun D
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884391
[TBL] [Abstract][Full Text] [Related]
4. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
6. Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad.
Bleve A; Durante B; Sica A; Consonni FM
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823961
[TBL] [Abstract][Full Text] [Related]
7. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
9. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
13. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages.
Wu H; Han Y; Rodriguez Sillke Y; Deng H; Siddiqui S; Treese C; Schmidt F; Friedrich M; Keye J; Wan J; Qin Y; Kühl AA; Qin Z; Siegmund B; Glauben R
EMBO Mol Med; 2019 Nov; 11(11):e10698. PubMed ID: 31602788
[TBL] [Abstract][Full Text] [Related]
14. The role of macrophages in the tumor microenvironment and tumor metabolism.
Sadhukhan P; Seiwert TY
Semin Immunopathol; 2023 Mar; 45(2):187-201. PubMed ID: 37002376
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer.
Fang Z; Wen C; Chen X; Yin R; Zhang C; Wang X; Huang Y
Oncotarget; 2017 Aug; 8(33):54173-54186. PubMed ID: 28903332
[TBL] [Abstract][Full Text] [Related]
16. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
Ren Y; Wang M; Yuan H; Wang Z; Yu L
Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
[TBL] [Abstract][Full Text] [Related]
17. VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.
Khan ANH; Emmons TR; Magner WJ; Alqassim E; Singel KL; Ricciuti J; Eng KH; Odunsi K; Tomasi TB; Lee K; Abrams SI; Mesa C; Segal BH
Cancer Immunol Immunother; 2022 Oct; 71(10):2355-2369. PubMed ID: 35166871
[TBL] [Abstract][Full Text] [Related]
18. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
Wang Y; Jia A; Bi Y; Wang Y; Liu G
Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
[TBL] [Abstract][Full Text] [Related]
20. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
